A double-edged sword: the role of macrophage pyroptosis-driven cytokine storm-mediated intercellular communication in tumor progression - Report - MDSpire

The Dual Role of Macrophage Pyroptosis-Induced Cytokine Storms in Tumor Development

  • By

  • Qing-feng Wang

  • Hong-le Li

  • Hong Gao

  • Li-jiang Zhou

  • Yue Sun

  • Hao-ran Wang

  • Jia-yi Zhou

  • July 21, 2026

Share

Clinical Report: The Dual Role of Macrophage Pyroptosis-Induced Cytokine Storms in Tumor Development

Overview

This review explores how macrophage pyroptosis-driven cytokine storms can either promote anti-tumor immunity or facilitate tumor progression, depending on the intensity and duration of the inflammatory response.

Background

Understanding the role of pyroptosis in tumor immunity is critical as it represents a significant mechanism by which inflammation can influence cancer progression. Pyroptosis induces an inflammatory response and shapes the tumor microenvironment, affecting immune cell recruitment and activity.

Data Highlights

No specific numerical data or trial data presented in the article.

Key Findings

  • Pyroptosis is executed through both canonical and non-canonical pathways, leading to the release of pro-inflammatory cytokines.
  • Acute, moderate cytokine storms can activate anti-tumor immunity, while chronic, low-grade storms promote tumorigenesis.
  • Six interconnected mechanisms by which chronic cytokine storms facilitate tumor progression include genomic instability and immunosuppressive microenvironment establishment.
  • Pyroptosis-related biomarkers may aid in patient stratification and treatment-response prediction across various cancers.
  • Current therapeutic strategies include NLRP3 inhibitors and IL-1β/IL-18 blockers.

Clinical Implications

The findings indicate that modulation of macrophage pyroptosis could be a therapeutic strategy to balance anti-tumor efficacy and inflammatory toxicity.

Conclusion

Macrophage pyroptosis plays a dual role in tumor development.

Related Resources & Content

  1. Frontiers in Immunology, 2026 -- The Link Between Macrophage Polarization and Response to Radiotherapy in Cancers: Mechanisms and Therapeutic Opportunities
  2. Journal of Gastroenterology, 2026 -- Stage-associated remodeling of CD169 macrophage states is linked to immune regulation in colitis-associated colorectal cancer
  3. Frontiers in Immunology, 2026 -- Dual inhibition of CSF-1R and IDO modulates the fibrotic and immunosuppressive tumor microenvironment in pancreatic ductal adenocarcinoma
  4. NCCN GUIDELINES® INSIGHTS, 2024 -- Management of Immunotherapy-Related Toxicities
  5. Nature Reviews Clinical Oncology, 2024 -- Current understanding and management of CAR T cell-associated toxicities
  6. Journal of Clinical Oncology, 2021 -- Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline
  7. Frontiers in Immunology — Macrophage polarization in gynecologic malignancies: key signaling pathways and clinical perspectives
  8. CE NCCN GUIDELINES® INSIGHTS Management of Immunot
  9. Current understanding and management of CAR T cell-associated toxicities | Nature Reviews Clinical Oncology
  10. Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline | Journal of Clinical Oncology

Original Source(s)

Related Content